We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The NCI60 human tumour cell line anticancer drug screen.
- Authors
Shoemaker, Robert H
- Abstract
The US National Cancer Institute (NCI) 60 human tumour cell line anticancer drug screen (NCI60) was developed in the late 1980s as an in vitro drug-discovery tool intended to supplant the use of transplantable animal tumours in anticancer drug screening. This screening model was rapidly recognized as a rich source of information about the mechanisms of growth inhibition and tumour-cell kill. Recently, its role has changed to that of a service screen supporting the cancer research community. Here I review the development, use and productivity of the screen, highlighting several outcomes that have contributed to advances in cancer chemotherapy.
- Publication
Nature reviews. Cancer, 2006, Vol 6, Issue 10, p813
- ISSN
1474-175X
- Publication type
Review
- DOI
10.1038/nrc1951